Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia

被引:132
作者
Waki, T
Tamura, G
Tsuchiya, T
Sato, K
Nishizuka, S
Motoyama, T
机构
[1] Yamagata Univ, Sch Med, Dept Pathol, Yamagata 9909585, Japan
[2] NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S0002-9440(10)64195-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Silencing of tumor suppressor and tumor-related genes by hypermethylation at promoter CpG islands is one of the major events in human tumorigenesis. Promoter methylation is also present in nonneoplastic cells as an age-related tissue-specific phenomenon that precedes the development of neoplasia. To clarify the significance of promoter methylation in nonneoplastic gastric epithelia as a precancerous signal, we investigated promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic cells of various organs obtained at autopsy, and compared the results with those of nonneoplastic epithelia of a cancerous stomach. Methylation of these genes was not seen in nonneoplastic cells of organs from people who were 22 years and younger (0%, 0 of 6). In contrast, E-cadherin and p16 were methylated in nonneoplastic gastric epithelia of persons who were 45 years or older. The numbers were 86% (12 of 14) and 29% (4 of 14), respectively. E-cadherin methylation occurred preferentially in the intestines, whereas p16 methylation was almost restricted to the stomach. For samples obtained from patients with stomach cancer, methylation was frequently observed in both neoplastic and corresponding nonneoplastic gastric epithelia: 47% (44 of 94) and 67% (63 of 94) for E-cadherin, 32% (30 of 94) and 24% (23 of 94) for hMLH1, and 22% (21 of 94) and 44% (41 of 94) for p16, respectively. hMLH1 methylation was not seen in nonneoplastic gastric epithelia from autopsy samples but occurred significantly in samples from nonneoplastic tissues of individuals with stomach cancer. Therefore, detection of hMLH1 methylation in nonneoplastic gastric epithelia may be useful for screening patients who may be at risk of developing gastric cancer.
引用
收藏
页码:399 / 403
页数:5
相关论文
共 20 条
  • [1] Ahuja N, 1998, CANCER RES, V58, P5489
  • [2] BOMMAN DM, 2001, AM J PATHOL, V159, P831
  • [3] Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype
    Endoh, Y
    Tamura, G
    Ajioka, Y
    Watanabe, H
    Motoyama, T
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (03) : 717 - 722
  • [4] Esteller M, 2001, CANCER RES, V61, P3225
  • [5] Fleisher AS, 1999, CANCER RES, V59, P1090
  • [6] Issa JP, 2000, CURR TOP MICROBIOL, V249, P101
  • [7] METHYLATION OF THE ESTROGEN-RECEPTOR CPG ISLAND LINKS AGING AND NEOPLASIA IN HUMAN COLON
    ISSA, JPJ
    OTTAVIANO, YL
    CELANO, P
    HAMILTON, SR
    DAVIDSON, NE
    BAYLIN, SB
    [J]. NATURE GENETICS, 1994, 7 (04) : 536 - 540
  • [8] Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis
    Issa, JPJ
    Vertino, PM
    Boehm, CD
    Newsham, IF
    Baylin, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) : 11757 - 11762
  • [9] Cancer epigenetics comes of age
    Jones, PA
    Laird, PW
    [J]. NATURE GENETICS, 1999, 21 (02) : 163 - 167
  • [10] Kang GH, 2001, CANCER RES, V61, P2847